Compound ID | 613
CP-544372
Class: Macrolide
| Spectrum of activity: | Gram-positive |
| Details of activity: | Analysed alongside two ketolides also in preclinical trials: HMR 3647 (Telithromycin) and HMR3004 against Pneumococcal and H. influenzae murine infections. CP-544372 was potent against Streptococcus pneumoniae isolates resistant to macrolides. |
| Description: | Girard D, Mathieu HW, Girard AE, et al. In vivo oral efficicacy of CP-544372, a new erthromycylamine C4 carbamate, against macrolide-resistant Pneumococci and Haemophilus influenzae. 38th-Intersci-Conf-Antimicrobial-Agents-Chemother 1998; 263. |
| Institute where first reported: | Pfizer, USA |
| Year first mentioned: | 1998 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.